RBS design was aided by RBS Calculator (version 2.0, Construction of genomic replacement mutants of C
1896, c
Rojas-Rivera, D
Disclosures: Antonio Moreno: Nothing to Disclose, Thomas Issa: Nothing to Disclose, Douglas Farmer: Nothing to Disclose, Edward Wolfgang Lee: Nothing to Disclose 2224 STATIN USE IN CIRRHOSIS CAN DECREASE RISK OF PORTAL HYPERTENSION AND MORTALITY Muhammad Ali Butt 1 Taimur Muzammil 1 Rahul Karna 2 Himsikhar Khataniar 1 Nabeeha Mohy-ud-din 3 , 1 Allegheny General Hospital, Pittsburgh, PA, 2 University of Minnesota Medical Center, 3 Division of Gastroenterology, Hepatology and Nutrition, Allegheny Health Network, Pittsburgh, PA Background: MASLD related cirrhosis is one of the leading etiologies of liver disease, and these patients frequently have other comorbidities like atherosclerotic cardiovascular disease (ASCVD), hyperlipidemia (HLD), cerebrovascular disease (CVD), and diabetes mellitus (DM)
Research involving Acetyl L-Carnitine shows promise in Degenerative brain diseases (dementia, alzheimers) Muscle decline from aging (sarcopenia), with 8.4 pound muscle gain in one study on 2 grams/day Enhanced fat reduction (about 4 pounds of fat lost on 2 grams/day in elderly individuals) Angina, heart attack, heart failure Peripheral neuropathy (nerve damage) Sexual dysfunction, like erectile problems Fatigue, especially muscle fatigue, with improved endurance Depression Insulin resistance and high blood sugars Lower cholesterol levels Mightier Mitochondria Mitochondria are your cell power plants and every cell has one, at least one
